Cargando…
An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers
• The extremely uncommon subtype of epithelial vaginal cancer. • Comprehensive genomic sequencing of the rare subtype vaginal cancer. • Incorporated of the actionable targeted drugs in the treatment of uncommon cancer based on the comprehensive genomic profile. • A promising response of uncommon dis...
Autores principales: | Hou, June Y., Wright, Jason D., Achariyapota, Vuthinun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212178/ https://www.ncbi.nlm.nih.gov/pubmed/32405522 http://dx.doi.org/10.1016/j.gore.2020.100577 |
Ejemplares similares
-
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2(S310F) mutated extramammary Paget’s disease
por: Nordmann, Thierry M., et al.
Publicado: (2019) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014) -
Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005) -
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
por: Ross, Jeffrey S., et al.
Publicado: (2018) -
ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report
por: Minuto, Michele, et al.
Publicado: (2018)